首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
ovarian endometrioid adenocarcinoma相关文献:
Ovarian involvement in endometrioid adenocarcinoma of uterus.
Lin KY, Miller DS, Bailey AA, Andrews SJ, Kehoe SM, Richardson DL, Lea JS.
Gynecol Oncol. 2015 Sep;138(3):532-5. doi: 10.1016/j.ygyno.2015.07.012. Epub 2015 Jul 14.
PMID:26186908
Paratesticular endometrioid adenocarcinoma of the ovarian surface epithelial type with neuroendocrine differentiation: an undescribed entity.
Mundada A, Kakkar A, Menon S.
Histopathology. 2022 Jan;80(2):443-445. doi: 10.1111/his.14447. Epub 2021 Sep 3.
PMID:34245593
A case of ovarian adenosquamous carcinoma arising from endometrioid adenocarcinoma: a case report and systematic review.
Shoji T, Takatori E, Murakami K, Kaido Y, Takeuchi S, Kikuchi A, Sugiyama T.
J Ovarian Res. 2016 Aug 11;9(1):48. doi: 10.1186/s13048-016-0255-6.
PMID:27514842
Synchronous endometrial endometrioid adenocarcinoma and ovarian endometrioid adenocarcinoma.
Rodríguez González E, Deavers M, Chang S, Suri A.
Int J Gynecol Cancer. 2024 Feb 5;34(2):332-338. doi: 10.1136/ijgc-2023-005201.
PMID:39163499
Ovarian endometrioid adenocarcinoma arising from an endometriotic cyst in a postmenopausal woman under tamoxifen therapy for breast cancer: a case report.
Okugawa K, Hirakawa T, Ogawa S, Kaku T, Nakano H.
Gynecol Oncol. 2002 Nov;87(2):231-4. doi: 10.1006/gyno.2002.6824.
PMID:12477460
Endometriosis-associated Ovarian Cancers.
Anglesio MS, Yong PJ.
Clin Obstet Gynecol. 2017 Dec;60(4):711-727. doi: 10.1097/GRF.0000000000000320.
PMID:28990985
Mesonephric-like Differentiation of Ovarian Endometrioid and High-grade Serous Carcinomas: Clinicopathological and Molecular Characteristics Distinct from Those of Mesonephric-like Adenocarcinoma.
Choi KH, Kim H, Bae GE, Lee SH, Woo HY, Kim HS.
Anticancer Res. 2021 Sep;41(9):4587-4601. doi: 10.21873/anticanres.15272.
PMID:34475087
Overexpression of Long Noncoding RNA E2F-Mediated Cell Proliferation Enhancing Long Noncoding RNA Is Involved in the Development of Chemoresistance of Cancer Cells to Carboplatin in Ovarian Endometrioid Adenocarcinoma.
Zhao L, Yang J, Liu X, Fu X, Ding Y, Wang C.
Cancer Biother Radiopharm. 2019 Nov;34(9):566-571. doi: 10.1089/cbr.2019.2851. Epub 2019 Oct 17.
PMID:31621389
Ovarian Endometrioid Carcinoma Misdiagnosed as Mucinous Carcinoma: An Underrecognized Problem.
Woodbeck R, Kelemen LE, Köbel M.
Int J Gynecol Pathol. 2019 Nov;38(6):568-575. doi: 10.1097/PGP.0000000000000564.
PMID:30480647
Clinical outcomes of levonorgestrel-releasing intrauterine device present during controlled ovarian stimulation in patients with early stage endometrioid adenocarcinoma and atypical endometrial hyperplasia after fertility-sparing treatments: 10-year experience in one tertiary hospital in China.
Yin J, Li Y, Wang H, Wang W, Gu Y, Jin Y, Deng C, Pan L.
Eur J Obstet Gynecol Reprod Biol. 2023 Jan;280:83-88. doi: 10.1016/j.ejogrb.2022.11.009. Epub 2022 Nov 11.
PMID:36436458
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3